- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Aurobindo Pharma China plant expected to be commercialised from Q3 FY25: CFO
![Aurobindo Pharma China plant expected to be commercialised from Q3 FY25: CFO Aurobindo Pharma China plant expected to be commercialised from Q3 FY25: CFO](https://medicaldialogues.in/h-upload/2024/04/08/750x450_235841-aurobindo-pharma-50.webp)
New Delhi: Hyderabad-based pharmaceutical company, Aurobindo Pharma anticipates that its China facility will begin production in the upcoming quarter, with full-scale output expected in the next fiscal year, as stated by Chief Financial Officer Santhanam Subramanian. The Company plans to commence a small-volume rollout during November-December and expects to increase it in the January-March quarter of the following year.
In an analyst call, Subramanian said, "Our China plant is expected to be commercialized from Q3 FY25, with a ramp-up expected in Q4 FY25."
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751